BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Gilead Sciences enters drug agreement with Tibotec Pharmaceuticals]]>http://www.bloggingstocks.com/2009/07/17/gilead-sciences-enters-drug-agreement-with-tibotec-pharmaceutica/http://www.bloggingstocks.com/2009/07/17/gilead-sciences-enters-drug-agreement-with-tibotec-pharmaceutica/http://www.bloggingstocks.com/2009/07/17/gilead-sciences-enters-drug-agreement-with-tibotec-pharmaceutica/#commentsFiled under:

Yesterday, Gilead Sciences (NASDAQ: GILD) announced that it entered a license and collaboration agreement with Tibotec Pharmaceuticals. The two firms will combine to develop and commercialize a new once-daily, fixed-dose treatment for HIV. GILD's CEO John Martin noted, "Gilead and Tibotec share a strong focus on bringing safe and effective treatment options to people living with HIV/AIDS."

If the collaboration is approved, GILD will assume the lead in manufacturing, registration, distribution, and commercialization of a fixed-dose combination of Truvada and rilpivirine. GILD will not be responsible for the commercialization of this combination in the developing world and Japan, which will be handled by Tibotec. The two companies will work toward an agreement to market the combination in the developing world.

Continue reading Gilead Sciences enters drug agreement with Tibotec Pharmaceuticals

Gilead Sciences enters drug agreement with Tibotec Pharmaceuticals originally appeared on BloggingStocks on Fri, 17 Jul 2009 12:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AIDSAIDS treatmentAidsTreatmentgildgilead sciencesGileadSciencesHIVinthenewspharmaceuticalsTibotecFri, 17 Jul 2009 12:20:00 EST